Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VANCOUVER, British Columbia & GRAPEVINE, Texas — Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced that on September 8, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards…
Alpha Cognition Inc., a biopharmaceutical company based in Vancouver, British Columbia and Grapevine, Texas, announced on September 8, 2026 that the Compensation Committee of its Board of Directors granted inducement awards to a new non-executive employee. The awards consist of nonstatutory stock options to purchase 25,000 shares of the company's common stock.
This grant is made under the company's 2026 Inducement Grant Plan, which is reserved for equity awards to individuals who have not previously worked for the company. The Compensation Committee approved these stock options to entice the new employee to join the company, in line with Nasdaq Listing Rule 5635(c)(4).
Written by urgent.news from Financial Post's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
